Clinical Trials Logo
  1. Home
  2. Metabolic Bone Disease
  3. NCT02853539

Denosumab in Metabolic Bone Disease in Chronic Intestinal Failure Patients — Denoz  

Metabolic Bone Disease Clinical Trial

Official title:
Denosumab Counteracts Metabolic Bone Disease in Chronic Intestinal Failure Patients: A Randomized, Controlled Clinical Trial

Clinical Trial Summary

Low bone mineral density (BMD) is commonly reported in patients receiving home parenteral nutrition (HPN). Denosumab represent a new drug, which helped to prevent osteoclast. The aim of the study was to assess its value in chronic intestinal failure patients.

Clinical Trial Description

Low bone mineral density (BMD) is commonly reported in patients receiving home parenteral nutrition (HPN). Oral and intravenous calcium, vitamin D and bisphosphonates have been commonly used to treat BMD, but their efficiency is may be inadequate due to limited absorption and compliance. Denosumab represent a new drug, which helped to prevent osteoclast development and activation, hence decreased bone resorption in some studies. The aim of the study was to assess its value in chronic intestinal failure patients receiving HPN.

Between November 2011 and March 2013 denosumab was administered to 16 HPN patients (9 F, 7 M mean age 55.4) with intestinal failure. Regional dual-energy x-ray absorptiometry of spine and hip were performed before the therapy was initiated, and after 12 months. BMD, T-score and Z-score were measured. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02853539
Study type Interventional
Source Stanley Dudrick's Memorial Hospital
Contact
Status Completed
Phase Phase 4
Start date January 2011
Completion date July 2016
View Details
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04752098 - A Study to Assess Metabolic Bone Disease of Prematurity Using an Acoustic Method N/A
Not yet recruiting NCT06199102 - The High Initial Dose of Monitored Vitamin D Supplementation in Preterm Infants. N/A
Completed NCT01002872 - The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23 ( FGF23) in Chronic Kidney Disease N/A
Completed NCT03878134 - Translational Development of Photon-counting CT Imaging N/A
Completed NCT01603472 - Markers of Bone Disease in Children on Parenteral Nutrition N/A
Completed NCT05909228 - Bone Markers in Pediatric IF
Completed NCT01041456 - Laparoscopic Revision From Biliopancreatic Diversion to Gastric Bypass N/A
Terminated NCT00711763 - Calciuric Effect and Cyclic Parenteral Nutrition in Preterm Infants
Completed NCT04356807 - Physical Therapy to Prevent Osteopenia in Preterm Infants N/A
Completed NCT03811873 - Assessment of Vertebral Fracture Risk for First Time Liver Transplant Candidates N/A
Completed NCT03371199 - The Association Between Hyponatremia and Osteoporosis in Patients With Epilepsy. N/A
Active, not recruiting NCT02843048 - Bariatric Surgery and Exercise Bone Trial N/A